JULY 2013, Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,476,074 | Specific gene polymorphisms in breast cancer diagnosis, prevention and treatment | University of South Carolina | 2-Jul-13 | United States |
8,497,067 | Restoration of nucleic acid from degraded or formalin-fixed and paraffin-embedded tissue and uses thereof | Albert Einstein College of Medicine of Yeshiva University | 30-Jul-13 | United States |
8,486,682 | .beta.-amylase, gene coding therefor and manufacturing method thereof | Amano Enzyme Inc. | 16-Jul-13 | Japan |
8,492,092 | Assay for Chlamydia trachomatis by amplification and detection of Chlamydia trachomatis PMPA gene | Becton, Dickinson and Company | 30-Jul-13 | United States |
8,486,632 | Method for the in vitro diagnosis of bronchopulmonary carcinoma by detection of major alternative transcripts of the KLK8 gene encoding kallikrein 8 and use thereof for prognosticating survival | Biomerieux | 16-Jul-13 | France |
8,492,090 | Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium | Board of Trustees of the University of Arkansas | 30-Jul-13 | United States |
8,476,011 | Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components | BP Corporation North America Inc. | 2-Jul-13 | United States |
8,481,279 | Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase | Cell Signaling Technology, Inc. | 9-Jul-13 | United States |
8,486,645 | Gene defects and mutant ALK kinase in human solid tumors | Cell Signaling Technology, Inc. | 16-Jul-13 | United States |
8,497,101 | Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions | Centre National de la Recherche Scientifique (CNRS) | 30-Jul-13 | France |
8,486,670 | Method of producing L-threonine using Escherichia coli strain with phosphoenolpyruvate carboxylase promoter replaced with cysteine synthase promoter | Cheiljedang Corp. | 16-Jul-13 | Korea |
8,481,321 | Compositions and methods for improved protein production | Danisco US Inc. | 9-Jul-13 | United States |
8,476,042 | Bacillus strain for increased protein production | Danisco US Inc. | 2-Jul-13 | United States |
8,486,679 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 16-Jul-13 | United States |
8,481,266 | DNA sequencing method and system | Hyk Gene Technology Co., Ltd. | 9-Jul-13 | China P. Rep. |
8,492,130 | FAD-conjugated glucose dehydrogenase gene | Ikeda Food Research Co., Ltd. | 30-Jul-13 | Japan |
8,476,044 | Method of nucleic acid amplification | Illumina, Inc. | 2-Jul-13 | Switzerland |
8,497,093 | Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof | Intrexon Corporation | 30-Jul-13 | United States |
8,481,293 | Mutant microorganisms having a high ability to produce putrescine and method for producing putrescine using the same | Korea Advanced Institute of Science and Technology | 9-Jul-13 | Korea |
8,476,055 | Method for preparing metal nanoparticle using metal binding protein | Korea Advanced Institute of Science and Technology | 2-Jul-13 | Korea |
8,497,120 | Human trophoblast stem cells and use thereof | Lee; Jau-Nan | 30-Jul-13 | Taiwan |
8,476,051 | Thermostable alcohol dehydrogenase derived from Thermococcus guaymasensis | Ma; Kesen | 2-Jul-13 | Canada |
8,476,020 | BRCA2 mutations and use thereof | Myriad Genetics, Inc. | 2-Jul-13 | United States |
8,492,117 | Expression of toxic genes in vivo in a non-natural host | New England Biolabs, Inc. | 30-Jul-13 | United States |
8,492,095 | Methods and compositions for amplification of RNA sequences | Nugen Technologies, Inc. | 30-Jul-13 | United States |
8,492,087 | Method of judging risk for onset of drug-induced granulocytopenia | Otsuka Pharmaceutical Co., Ltd. | 30-Jul-13 | Japan |
8,497,128 | Genetic modification of homolactic thermophilic bacilli | Purac Biochem B.V. | 30-Jul-13 | Netheerlands |
8,492,089 | Subtractive single label comparative hybridization | Quest Diagnostics Investments Incorporated | 30-Jul-13 | United States |
8,486,647 | Neuropeptide release assay for sodium channels | Regeneron Pharmaceuticals, Inc. | 16-Jul-13 | United States |
8,497,070 | Angiogenin mutations and amyotrophic lateral sclerosis or motor neuron disease | Royal College of Surgeons in Ireland | 30-Jul-13 | Ireland |
8,486,624 | Lafora's disease gene | The Hospital for Sick Children | 16-Jul-13 | Canada |
8,492,122 | Molecular switches and methods for making and using the same | The Johns Hopkins University | 30-Jul-13 | United States |
8,492,083 | MicroRNA fingerprints during human megakaryocytopoiesis | The Ohio State University | 30-Jul-13 | United States |
8,476,023 | Methods relating to aromatase inhibitor pharmacogenetics | The Penn State Research Foundation | 2-Jul-13 | United States |
8,481,260 | Methods for diagnosing episodic movement disorders and related conditions | The Regents of the University of Michigan | 9-Jul-13 | United States |
8,486,687 | Sporulation-deficient thermophilic microorganisms for the production of ethanol | TMO Renewables Limited | 16-Jul-13 | United Kingdom |
8,486,701 | ETS2 and MESP1 generate cardiac progenitors from fibroblasts | University of Houston | 16-Jul-13 | United States |
8,486,698 | Differentiation of bone marrow cells into neuronal cells and uses therefor | University of Medicine and Dentistry of New Jersey | 16-Jul-13 | United States |
8,481,270 | Method for chromogenic detection of two or more target molecules in a single sample | Ventana Medical Systems, Inc. | 9-Jul-13 | United States |
8,497,096 | Methods and materials for increasing expression of recombinant polypeptides | XOMA Technology Ltd. | 30-Jul-13 | United States |
COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,476,200 | Method for differentiating between the non-infectious and infectious causes of multiple organ failure | SIRS-Lab GmbH | 2-Jul-13 | Germany |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,489,531 | Identification of co-regulation patterns by unsupervised cluster analysis of gene expression data | Health Discovery Corporation | 16-Jul-13 | United States |
8,478,541 | Extracting gene-gene interactions from gene expression data | Indian Statistical Institute | 2-Jul-13 | India |
8,483,970 | Method for identifying aQTL regions whose genotype modulates transcription factor activity | The Trustees of Columbia University in the city of New York | 9-Jul-13 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,481,052 | Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same | CJ Cheiljedang Corporation | 9-Jul-13 | Korea |
8,486,905 | Use of FLJ25416 gene | Korea Research Institute of Bioscience and Biotechnology | 16-Jul-13 | Korea |
8,486,401 | Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF | Lay Line Genomics S.p.A. | 16-Jul-13 | Italy |
8,476,242 | Pre-conditioning/fixation for disease treatment heat activation/release with thermo-activated drugs and gene products | Medifocus, Inc | 2-Jul-13 | United States |
8,497,252 | Compositions comprising cardiac stem cells overexpressing specific microRNAs and methods of their use in repairing damaged myocardium | New York Medical College | 30-Jul-13 | United States |
8,481,050 | Tissue culture system for production of hepatitis C virus | Novartis Vaccines and Diagnostics, Inc. | 9-Jul-13 | United States |
8,481,513 | 3, 10, and 12a substituted tetracycline compounds | Paratek Pharmaceuticals, Inc. | 9-Jul-13 | United States |
8,481,505 | Compositions and methods for the diagnosis and therapy of BCL2-associated cancers | The Ohio State University Research Foundation | 9-Jul-13 | United States |
8,486,907 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | The University of Western Australia | 16-Jul-13 | Australia |
8,476,243 | Methods and compositions for treating keratin hyperproliferative disorders | Transderm, Inc. | 2-Jul-13 | United States |
8,497,292 | Translational dysfunction based therapeutics | Translational Therapeutics, Inc. | 30-Jul-13 | United States |
8,492,365 | 7-substituted tetracycline compounds | Trustees of Tufts College | 30-Jul-13 | United States |
8,481,508 | Ultra-small RNAs as toll-like receptor-3 antagonists | University of Kentucky Research Foundation | 9-Jul-13 | United States |
8,475,807 | Avian influenza virus live attenuated vaccine and uses thereof | University of Maryland College Park | 2-Jul-13 | United States |
8,486,911 | Th1-associated microRNAs and their use for tumor immunotherapy | University of Pittsburgh--Of the Commonwealth System of Higher Education | 16-Jul-13 | United States |
8,481,504 | Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications | VGX Pharmaceuticals, Inc. | 9-Jul-13 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,492,615 | Brassica oleracea plants with a resistance to mycosphaerella brassicicola | Bejo Zaden B.V. | 30-Jul-13 | Netheerlands |
8,476,492 | Method of utilizing the pts gene and anti-sense ads to increase patchouli alcohol content in Artemisia annua L | Firmenich Aromatics (China) Co., Ltd. | 2-Jul-13 | China P. Rep. |
8,476,491 | Method of utilizing the PTS gene and RNA interference of the ads gene to increase patchouli alcohol content in Artemisia annua L. | Firmenich Aromatics (China) Co., Ltd. | 2-Jul-13 | China P. Rep. |
8,476,490 | Method for production of moth orchid having modified flower color | Ishihara Sangyo Kaisha, Ltd. | 2-Jul-13 | Japan |
8,487,157 | Transgenic rodents having NGF beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins | Staidson (Beijing) Pharmaceutical Co., Ltd. | 16-Jul-13 | China P. Rep. |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,497,351 | Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer | Agensys, Inc. | 30-Jul-13 | United States |
8,497,350 | Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402 | University of Iowa Research Foundation | 30-Jul-13 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,497,364 | Triggered RNAi | California Institute of Technology | 30-Jul-13 | United States |
8,481,709 | Mycobacterial peptide deformylase | Council of Scientific and Industrial Research | 9-Jul-13 | India |
8,497,362 | Plant diacylglycerol acyltransferases | E I du Pont de Nemours and Company | 30-Jul-13 | United States |
8,481,706 | Method for overproducing specific recombinant protein with P. cinnabarinus monokaryotic strains | Institut National de la Recherche Agronomique | 9-Jul-13 | France |
8,481,700 | Detection of mage-A expression | MDxHealth SA | 9-Jul-13 | Belgium |
8,487,087 | Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same | Oriental Yeast Co., Ltd. | 16-Jul-13 | Japan |
8,486,913 | MicroRNA fingerprints during human megakaryocytopoiesis | The Ohio State University | 16-Jul-13 | United States |
8,486,912 | MicroRNA fingerprints during human megakaryocytopoiesis | The Ohio State University Research Foundation | 16-Jul-13 | United States |
8,476,423 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | The University of Western Austrailia | 2-Jul-13 | Australia |
8,476,420 | Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells | The Wistar Institute of Anatomy and Biology | 2-Jul-13 | United States |
8,481,708 | snRNA gene-like transcriptional units and uses thereof | Universita degli Studi di Genova | 9-Jul-13 | Italy |
SURGERY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,480,662 | Systems and devices for photoablation | Cardiac Pacemakers, Inc. | 9-Jul-13 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.